Carey Chern

This profile gathers the share dealings of Carey Chern in Sciclone Pharmaceuticals Inc. Altogether 3 filings, all relating to 13 October 2017.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 16 October 2017, the filings show an option exercise in Sciclone Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.